A model for the activation of the epidermal growth factor receptor kinase: Involvement of an asymmetric dimer?

被引:32
作者
Groenen, LC [1 ]
Walker, F [1 ]
Burgess, AW [1 ]
Treutlein, HR [1 ]
机构
[1] ROYAL MELBOURNE HOSP, COOPERAT RES CTR CELLULAR GROWTH FACTORS, PARKVILLE, VIC 3050, AUSTRALIA
关键词
PROTEIN-TYROSINE KINASE; CYCLIN-DEPENDENT KINASE-2; HUMAN INSULIN-RECEPTOR; CRYSTAL-STRUCTURE; EGF RECEPTOR; CATALYTIC DOMAIN; SELF-PHOSPHORYLATION; POINT MUTATION; LIVING CELLS; MICE LACKING;
D O I
10.1021/bi9614141
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The binding of epidermal growth factor (EGF) to its receptor leads to receptor dimerization, which activates the intracellular kinase domain. Homology models of the inactive and active forms of the EGF-receptor kinase domains have been derived, and these models suggest that the active form can be stabilized by the interaction of helix C and the surrounding area in one receptor monomer with one of two possible complementary surfaces on a second receptor monomer. Both hydrophobic interaction sites are strongly conserved within the EGF-receptor family but not in other tyrosine kinases. Two of the three predicted kinase dimers are symmetric; the other is asymmetric and is predicted to contain only one active kinase. One of the symmetric models and the asymmetric model would account for the effects of two mutations in helix C (Y740F and V741G) on kinase activity. They also provide an explanation for previously reported dominant negative mutants of the EGF receptor and have interesting implications for the signaling through homo- and heterodimers of the family members: EGF receptor, erbB2, erbB3, and erbB4.
引用
收藏
页码:3826 / 3836
页数:11
相关论文
共 64 条
  • [1] RULES FOR ALPHA-HELIX TERMINATION BY GLYCINE
    AURORA, R
    SRINIVASAN, R
    ROSE, GD
    [J]. SCIENCE, 1994, 264 (5162) : 1126 - 1130
  • [2] PROTEIN DATA BANK - COMPUTER-BASED ARCHIVAL FILE FOR MACROMOLECULAR STRUCTURES
    BERNSTEIN, FC
    KOETZLE, TF
    WILLIAMS, GJB
    MEYER, EF
    BRICE, MD
    RODGERS, JR
    KENNARD, O
    SHIMANOUCHI, T
    TASUMI, M
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 1977, 112 (03) : 535 - 542
  • [3] MECHANISM OF EPIDERMAL GROWTH-FACTOR RECEPTOR AUTOPHOSPHORYLATION AND HIGH-AFFINITY BINDING
    BONISCHNETZLER, M
    PILCH, PF
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (22) : 7832 - 7836
  • [4] THE EPIDERMAL GROWTH-FACTOR
    BOONSTRA, J
    RIJKEN, P
    HUMBEL, B
    CREMERS, F
    VERKLEIJ, A
    HENEGOUWEN, PVE
    [J]. CELL BIOLOGY INTERNATIONAL, 1995, 19 (05) : 413 - 430
  • [5] CHARMM - A PROGRAM FOR MACROMOLECULAR ENERGY, MINIMIZATION, AND DYNAMICS CALCULATIONS
    BROOKS, BR
    BRUCCOLERI, RE
    OLAFSON, BD
    STATES, DJ
    SWAMINATHAN, S
    KARPLUS, M
    [J]. JOURNAL OF COMPUTATIONAL CHEMISTRY, 1983, 4 (02) : 187 - 217
  • [6] Brunger A. T., 1992, Version 3.1: a system for X-ray crystallography and NMR
  • [7] SIGNAL TRANSMISSION BY EPIDERMAL GROWTH-FACTOR RECEPTOR - COINCIDENCE OF ACTIVATION AND DIMERIZATION
    CANALS, F
    [J]. BIOCHEMISTRY, 1992, 31 (18) : 4493 - 4501
  • [8] A NEU ACQUAINTANCE FOR ERBB3 AND ERBB4 - A ROLE FOR RECEPTOR HETERODIMERIZATION IN GROWTH SIGNALING
    CARRAWAY, KL
    CANTLEY, LC
    [J]. CELL, 1994, 78 (01) : 5 - 8
  • [9] TISSUE-SPECIFIC TRANSFORMATION BY ONCOGENIC MUTANTS OF EPIDERMAL GROWTH-FACTOR RECEPTOR
    CARTER, TH
    KUNG, HJ
    [J]. CRITICAL REVIEWS IN ONCOGENESIS, 1994, 5 (04): : 389 - 428
  • [10] CHANTRY A, 1995, J BIOL CHEM, V270, P3068